RNU6-635P

Across TCGA pan-cancer cohorts, RNU6-635P RNA is linked to patient survival in 3 of 34 cancer types, making it the most broadly survival-associated RNU6-635P data layer.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher RNU6-635P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RNU6-635P expression acts as an unfavorable survival marker.

KIRC, SARC, and STAD are the cancer types where RNU6-635P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRC	DFS	Tertile	IV	0.127	0.619	.008	36	view →
SARC	OS	Tertile	All	0.022	0.861	<.001	36	view →
STAD	OS	Tertile	All	0.357	0.739	.001	18	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

RNU6-635P–KIRC (DFS)

Open the KIRC breakdown →